Hubei Biocause Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 000627?
Owner Type	Number of Shares	Ownership Percentage
Institutions	269,657,482	5.46%
Individual Insiders	1,152,238,287	23.3%
General Public	1,317,075,219	26.7%
Private Companies	2,201,658,177	44.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.29% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
44.6%	Sunline Group Co., Ltd.	2,201,658,177	CN¥11.0b	0%	no data
11.3%	Wei Wang	555,604,700	CN¥2.8b	0%	no data
10.5%	Yiqian Liu	517,500,000	CN¥2.6b	0%	no data
1.42%	Yangchao Wang	70,323,488	CN¥352.3m	0%	no data
1.33%	China Merchants Securities Asset Management Co., Ltd.	65,686,372	CN¥329.1m	0%	4.63%
0.94%	Minsheng Royal Fund Management Co., Ltd.	46,399,066	CN¥232.5m	0%	1.35%
0.81%	Gfund Management Co., Ltd.	39,918,100	CN¥200.0m	0%	0.72%
0.39%	Founder Fubon Fund Management Co., Ltd.	19,201,000	CN¥96.2m	0%	0.93%
0.32%	CITIC Securities Company Limited, Asset Management Arm	16,010,638	CN¥80.2m	0%	0.08%
0.28%	Fuli Tianrui Huashang Investment Management Co., Ltd.	13,690,995	CN¥68.6m	0%	no data
0.25%	The Vanguard Group, Inc.	12,303,900	CN¥61.6m	2.89%	no data
0.24%	China International Capital Corporation Hong Kong Asset Management Limited	11,774,456	CN¥59.0m	0%	0.3%
0.24%	GF Fund Management Co., Ltd.	11,656,400	CN¥58.4m	0%	0.02%
0.18%	China Southern Asset Management Co., Ltd.	8,870,400	CN¥44.4m	0%	0.01%
0.18%	Ziming He	8,810,099	CN¥44.1m	0%	no data
0.15%	Dimensional Fund Advisors LP	7,359,372	CN¥36.9m	0%	no data
0.1%	China Asset Management Co. Ltd.	5,095,500	CN¥25.5m	0%	no data
0.053%	China Merchants Fund Management Company Ltd.	2,617,500	CN¥13.1m	0%	0.01%
0.048%	Fullgoal Fund Management Co. Ltd.	2,379,649	CN¥11.9m	0%	no data
0.02%	State Street Global Advisors, Inc.	968,800	CN¥4.9m	2.12%	no data
0.016%	Guotai Asset Management Company Limited	805,800	CN¥4.0m	0%	no data
0.016%	China Universal Asset Management Company Ltd.	802,400	CN¥4.0m	0%	no data
0.016%	E Fund Management Co., Ltd.	788,600	CN¥4.0m	0%	no data
0.0098%	Hwabao WP Fund Management Co., Ltd	482,800	CN¥2.4m	0%	no data
0.0096%	Bosera Asset Management Co., Ltd.	473,400	CN¥2.4m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 13:46
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Biocause Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jun Liu	Changjiang Securities Co. LTD.
Yeyong Meng	SWS Research Co., Ltd.